Pharmaceuticals Global Industry Guide 2013-2022
Summary
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
- Any currency conversions used in the production of this report have been calculated at constant 2017 annual average exchange rates.
- The global pharmaceuticals market had total revenues of $1,066.5bn in 2017, representing a compound annual growth rate (CAGR) of 5.9% between 2013 and 2017.
- Globally, both physicians and the public are much more accepting of generics than in previous years.
- The US, China, and Japan are the largest global pharmaceutical markets followed by the four biggest European markets: Germany, France, Spain, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the global pharmaceuticals market by value in 2017?
- What will be the size of the global pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?
Pharmaceuticals Global Industry Guide 2013-2022
Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Introduction 20
What is this report about? 20
Who is the target reader? 20
How to use this report 20
Definitions 20
Global Pharmaceuticals 21
Market Overview 21
Market Data 22
Market Segmentation 23
Market outlook 25
Five forces analysis 26
Pharmaceuticals in Asia-Pacific 36
Market Overview 36
Market Data 37
Market Segmentation 38
Market outlook 40
Five forces analysis 41
Pharmaceuticals in Europe 51
Market Overview 51
Market Data 52
Market Segmentation 53
Market outlook 55
Five forces analysis 56
Pharmaceuticals in France 66
Market Overview 66
Market Data 67
Market Segmentation 68
Market outlook 70
Five forces analysis 71
Macroeconomic indicators 79
Pharmaceuticals in Germany 81
Market Overview 81
Market Data 82
Market Segmentation 83
Market outlook 85
Five forces analysis 86
Macroeconomic indicators 95
Pharmaceuticals in Italy 97
Market Overview 97
Market Data 98
Market Segmentation 99
Market outlook 101
Five forces analysis 102
Macroeconomic indicators 111
Pharmaceuticals in Japan 113
Market Overview 113
Market Data 114
Market Segmentation 115
Market outlook 117
Five forces analysis 118
Macroeconomic indicators 127
Pharmaceuticals in Australia 129
Market Overview 129
Market Data 130
Market Segmentation 131
Market outlook 133
Five forces analysis 134
Macroeconomic indicators 143
Pharmaceuticals in Canada 145
Market Overview 145
Market Data 146
Market Segmentation 147
Market outlook 149
Five forces analysis 150
Macroeconomic indicators 159
Pharmaceuticals in China 161
Market Overview 161
Market Data 162
Market Segmentation 163
Market outlook 165
Five forces analysis 166
Macroeconomic indicators 175
Pharmaceuticals in The Netherlands 177
Market Overview 177
Market Data 178
Market Segmentation 179
Market outlook 181
Five forces analysis 182
Macroeconomic indicators 191
Pharmaceuticals in Spain 193
Market Overview 193
Market Data 194
Market Segmentation 195
Market outlook 197
Five forces analysis 198
Macroeconomic indicators 207
Pharmaceuticals in The United Kingdom 209
Market Overview 209
Market Data 210
Market Segmentation 211
Market outlook 213
Five forces analysis 214
Macroeconomic indicators 223
Pharmaceuticals in The United States 225
Market Overview 225
Market Data 226
Market Segmentation 227
Market outlook 229
Five forces analysis 230
Macroeconomic indicators 240
Company Profiles 242
Leading Companies 242
Appendix 311
Methodology 311
About MarketLine 312
List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2013-17
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Global pharmaceuticals market share: % share, by value, 2017
Table 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2017
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Table 9: Europe pharmaceuticals market value: $ billion, 2013-17
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2017
Table 11: Europe pharmaceuticals market share: % share, by value, 2017
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Table 13: France pharmaceuticals market value: $ billion, 2013-17
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2017
Table 15: France pharmaceuticals market share: % share, by value, 2017
Table 16: France pharmaceuticals market value forecast: $ billion, 2017-22
Table 17: France size of population (million), 2013-17
Table 18: France gdp (constant 2005 prices, $ billion), 2013-17
Table 19: France gdp (current prices, $ billion), 2013-17
Table 20: France inflation, 2013-17
Table 21: France consumer price index (absolute), 2013-17
Table 22: France exchange rate, 2013-17
Table 23: Germany pharmaceuticals market value: $ billion, 2013-17
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2017
Table 25: Germany pharmaceuticals market share: % share, by value, 2017
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Table 27: Germany size of population (million), 2013-17
Table 28: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 29: Germany gdp (current prices, $ billion), 2013-17
Table 30: Germany inflation, 2013-17
Table 31: Germany consumer price index (absolute), 2013-17
Table 32: Germany exchange rate, 2013-17
Table 33: Italy pharmaceuticals market value: $ billion, 2013-17
Table 34: Italy pharmaceuticals market geography segmentation: $ billion, 2017
Table 35: Italy pharmaceuticals market share: % share, by value, 2017
Table 36: Italy pharmaceuticals market value forecast: $ billion, 2017-22
Table 37: Italy size of population (million), 2013-17
Table 38: Italy gdp (constant 2005 prices, $ billion), 2013-17
Table 39: Italy gdp (current prices, $ billion), 2013-17
Table 40: Italy inflation, 2013-17
Table 41: Italy consumer price index (absolute), 2013-17
Table 42: Italy exchange rate, 2013-17
Table 43: Japan pharmaceuticals market value: $ billion, 2013-17
Table 44: Japan pharmaceuticals market geography segmentation: $ billion, 2017
Table 45: Japan pharmaceuticals market share: % share, by value, 2017
Table 46: Japan pharmaceuticals market value forecast: $ billion, 2017-22
Table 47: Japan size of population (million), 2013-17
Table 48: Japan gdp (constant 2005 prices, $ billion), 2013-17
Table 49: Japan gdp (current prices, $ billion), 2013-17
Table 50: Japan inflation, 2013-17
Table 51: Japan consumer price index (absolute), 2013-17
Table 52: Japan exchange rate, 2013-17
Table 53: Australia pharmaceuticals market value: $ billion, 2013-17
Table 54: Australia pharmaceuticals market geography segmentation: $ billion, 2017
Table 55: Australia pharmaceuticals market share: % share, by value, 2017
Table 56: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Table 57: Australia size of population (million), 2013-17
Table 58: Australia gdp (constant 2005 prices, $ billion), 2013-17
Table 59: Australia gdp (current prices, $ billion), 2013-17
Table 60: Australia inflation, 2013-17
Table 61: Australia consumer price index (absolute), 2013-17
Table 62: Australia exchange rate, 2013-17
List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2013-17
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Global pharmaceuticals market share: % share, by value, 2017
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the global pharmaceuticals market, 2017
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2017
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2017
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2017
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2017
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2017
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017
Figure 21: Europe pharmaceuticals market value: $ billion, 2013-17
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 23: Europe pharmaceuticals market share: % share, by value, 2017
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2017
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2017
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2017
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017
Figure 31: France pharmaceuticals market value: $ billion, 2013-17
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 33: France pharmaceuticals market share: % share, by value, 2017
Figure 34: France pharmaceuticals market value forecast: $ billion, 2017-22
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2017
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2017
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2017
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2017
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2017
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2017
Figure 41: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 43: Germany pharmaceuticals market share: % share, by value, 2017
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 51: Italy pharmaceuticals market value: $ billion, 2013-17
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
